Glucagon-like peptide-1 signifies a remarkable breakthrough in the loss landscape . Originally intended to treat type 2 diabetes , these medications have revealed noteworthy ability to promote weight reduction and enhance body well-being . Scientists actively exploring their potential in treating obesity among individuals who don’t have a diabet